| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±2.8% | +2.1% | over-priced |
| 04/28/2026 | ±3.0% | +6.9% | under-priced |
| 01/30/2026 | ±2.0% | +2.9% | under-priced |
| 08/01/2025 | ±1.8% | -0.2% | over-priced |
| 05/02/2025 | ±2.0% | +7.0% | under-priced |
| 01/31/2025 | ±2.3% | +10.4% | under-priced |
| 04/29/2024 | ±1.9% | -6.4% | under-priced |
| 01/29/2024 | ±2.4% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.31 | $2.4B | $255M |
| Q2 FY2026 | $0.49 | $2.3B | $347M |
| Q1 FY2026 | $0.46 | $2.3B | $347M |
| Q4 FY2025 | $0.21 | $2.3B | $189M |
Franklin Templeton, Inc. (BEN) reports in 72 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 4.5% on average — the market has been roughly fair on BEN's earnings risk. Fundamentals into the print: EPS up 106.7% year-over-year, revenue up 14.3%. QuantLogix's live 5-factor engine currently reads BEN as a neutral at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →